Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy for Malignant Supratentorial Brain Tumors
NCT00003788Phase 3Unknown
- Sponsor
- Colorado Health Foundation
- Start
- Apr 1998
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of porfimer sodium in glioblastoma (GBM) and malignant astrocytoma (4 arms), sponsored by Colorado Health Foundation. Primary endpoints: Time to Recurrence and Overall Survival. Status: unknown.
02
Drugs
porfimer sodium
03
Conditions
glioblastoma (GBM)malignant astrocytoma
Beyond the preview
Go deeper on NCT00003788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003788.